Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones TSAT Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Amid Revenue Disclosures Still Pending Inhibikase Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss but Stock Declines XP Q1 2026 Earnings EPS Miss and Stock Decline Signal Headwinds News Corporation NWS Q1 2026 Earnings EPS Beats Estimates by 1206 Despite Stock Decline BioRad BIO Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher Despite Headwinds